Leading pulmonologists talk about latest advances in treatment options for post-COVID pulmonary fibrosis
Experts presented various data generated from studies investigating the Russian drug Longidaza® when used in patients with residual pulmonary abnormalities after COVID-19 at the 21st Century Pulmonology National Congress held in Moscow.
“Thinking and reflection of the present and future of patients recovered from COVID-19”: how to treat post-COVID syndrome?”
Health professionals discussed rehabilitation for patients recovered from COVID-19
Breathe freely: lung recovery from COVID-19
Post-COVID syndrome: treat, not ignore
News in post-COVID-19 syndrome treatment and rehabilitation as discussed at sites of the 31st National Congress on Respiratory Diseases
